Alpinumisoflavone, an anticancer drug for the treatment of HCC, could effectively induce cancer cell pyroptosis through NLRP3 inflammasome‐dependent pathway to increase the expression of pyroptosis‐related genes for enhanced tumor inhibition.271. This evidence concerns the gene NLRP3 and cancer.